Trader Note — 9342 total
GE Vernova heads into its July 22 Q2 earnings report having surged 13.5% on the week to $1,174.86 — a sharp reversal from the 8% single-day drop documented in last week's note, and a move that has arrived alongside two…
RDDT closes out June with short sellers at their most aggressive positioning in months — and Q2 earnings now less than four weeks away. The short interest story has moved decisively since last week's note. Bearish…
Since yesterday's convergence note flagged the initial short build, SBET has seen every bearish signal move another notch tighter — short interest is now at its highest level in months, the borrow pool has contracted…
HUT heads into July with an unusual split: short sellers have been cutting positions aggressively while options traders are now the most call-heavy they've been in months — a setup that points to rebuilding confidence…
Banc of California heads into its July 22 earnings date with a mixed but increasingly constructive setup — analysts turning more positive, shorts modestly rebuilding, and options sentiment at its least defensive in…
VSTS enters July with an unusual tension: the stock is up 10% on the week to $14.52, yet short sellers quietly added to positions over the same period. That rebuilding of short conviction is the week's most interesting…
BIRK enters July in an unusual split: short sellers have been covering aggressively, yet the borrow market has tightened to near-zero and options traders are the most defensively positioned they have been in…
Lithium Americas Corp. enters July with a striking internal contradiction: the stock is down 7% on the week and 24% over the past month, yet the borrow market has suddenly tightened after weeks of relative ease. The…
IBIT enters July with short sellers materially more aggressive than a month ago, even as the broader borrow market remains wide open — a divergence that makes the recent positioning shift worth watching closely. The…
BTQ Technologies heads into July with a striking disconnect: borrow costs have more than doubled in a month while short interest itself remains negligible, pointing to something more structural happening in the lending…
Intuitive Machines enters July with a striking split between what insiders are doing and what the Street is saying — and the short book is quietly catching up with both. The most conspicuous signal this week is insider…
GRND enters July with its most constructive analyst backdrop in months, after a bellwether upgrade landed just as the stock wrapped up a 9% weekly gain. The catalyst is fresh. Morgan Stanley's Nathan Feather upgraded…
FirstSun Capital Bancorp enters July with a fresh analyst upgrade on one side of the ledger and a meaningful week-on-week jump in short interest on the other — an unusual pairing for a stock that just logged a 4.7%…
Symbotic closed the week at $44.95, up 17% in five sessions — yet short interest climbed in near-lockstep, rising 10.5% over the same period to 14.5% of the free float. That tension between price and positioning is the…
QuidelOrtho has staged a striking 47% recovery over the past month — yet short sellers are not retreating, the Street's price targets sit well below the current price, and the next earnings test is less than four weeks…
FTAI Infrastructure enters July with a rare divergence: the stock just posted its best single-day gain in weeks, yet the options market has simultaneously flipped to its most defensive posture on record. The options…
Haleon heads into its July 30 results with a tidy 4.2% weekly gain and an almost complete absence of short-side pressure — a combination that leaves the setup looking calm rather than charged. The lending market tells…
Warner Bros. Discovery enters July with a fresh upgrade from Seaport Global cutting against an unrelenting wave of insider selling — the tension between those two signals defines the stock right now. The most notable…
NRGV enters July with short sellers building aggressively and the borrow market tightening at a pace that has few recent parallels — a combination that makes the stock's 11% weekly rally all the more striking. The…
MoonLake Immunotherapeutics ends the week in retreat — down 8.2% to $19.47 — with insiders still distributing stock and the extreme options bullishness flagged last week having quietly unwound. The insider selling is…
